Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Glivec in intermediate and high-risk localized GIST
NCT00103168Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 2004; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00103168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103168.